Progress of Nimotuzumab Application in Nasopharyngeal Carcinoma

Compared with the global average, the incidence rate of nasopharyngeal carcinoma (NPC) in China is higher, particularly in the southern regions where the mortality rate has remained persistently high. Nimotuzumab, a targeted therapy that acts on the epidermal growth factor receptor, has prompted con...

Description complète

Détails bibliographiques

Auteurs principaux:	Tianci LIANG, Yue ZHAO, Chenchen SONG, Chaoyi ZHANG, Chen CHEN, Qiaoran LI, Biaoxue RONG
Format:	Artigo
Langue:	Chinês
Publié:	Magazine House of Cancer Research on Prevention and Treatment 2024-11-01
Collection:	Zhongliu Fangzhi Yanjiu
Sujets:	nasopharyngeal carcinoma nimotuzumab epidermal growth factor receptor targeted therapy antitumor treatment
Accès en ligne:	http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2024.24.0362
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!